HSBC Holdings’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.9M | Buy |
|
|||||
|
2025
Q2 | $11.6M | Sell |
|
|||||
|
2025
Q1 | $12.3M | Buy |
|
|||||
|
2024
Q4 | $14.8M | Sell |
|
|||||
|
2024
Q3 | $16.1M | Sell |
|
|||||
|
2024
Q2 | $20.4M | Buy |
|
|||||
|
2024
Q1 | $20.9M | Buy |
|
|||||
|
2023
Q4 | $13.3M | Sell |
|
|||||
|
2023
Q3 | $12.4M | Buy |
|
|||||
|
2023
Q2 | $11.4M | Buy |
|
|||||
|
2023
Q1 | $8.72M | Sell |
|
|||||
|
2022
Q4 | $11.4M | Buy |
|
|||||
|
2022
Q3 | $7.11M | Buy |
|
|||||
|
2022
Q2 | $7.91M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Buy |
|
|||||
|
2021
Q4 | $16.6M | Buy |
|
|||||
|
2021
Q3 | $16.5M | Buy |
|
|||||
|
2021
Q2 | $11.8M | Buy |
|
|||||
|
2021
Q1 | $1.8M | Sell |
|
|||||
|
2020
Q4 | $1.88M | Buy |
|
|||||
|
2020
Q3 | $622K | Buy |
|
|||||
|
2020
Q2 | $278K | Sell |
|
|||||
|
2020
Q1 | $255K | Sell |
|
|||||
|
2019
Q4 | $1.12M | Sell |
|
|||||
|
2019
Q3 | $1.07M | Sell |
|
|||||
|
2019
Q2 | $5.44M | Buy |
|
|||||
|
2019
Q1 | $822K | Sell |
|
|||||
|
2018
Q4 | $1.38M | Buy |
|
|||||
|
2018
Q3 | $538K | Sell |
|
|||||
|
2018
Q2 | $5.13M | Buy |
|
|||||
|
2018
Q1 | $3.05M | Buy |
|
|||||
|
2017
Q4 | $403K | Buy |
|
|||||
|
2017
Q3 | $323K | Buy |
|
|||||
|
2017
Q2 | $244K | Sell |
|
|||||
|
2017
Q1 | $296K | Hold |
|
|||||
|
2016
Q4 | $251K | Buy |
|
|||||
|
2016
Q3 | $251K | Sell |
|
|||||
|
2016
Q2 | $302K | Buy |
|
|||||
|
2016
Q1 | $274K | Sell |
|
|||||
|
2015
Q4 | $290K | Sell |
|
|||||
|
2015
Q3 | $267K | Buy |
|
|||||
|
2015
Q2 | $163K | Sell |
|
|||||
|
2015
Q1 | $371K | Buy |
|